Studies Back Neoadjuvant Strategies for Melanoma Studies Back Neoadjuvant Strategies for Melanoma
Two analyses of neoadjuvant immunotherapy support more rigorous study with RCTs of neoadjuvant vs adjuvant strategies for melanoma, says Dr Weber.Medscape Oncology
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Hematology-Oncology Commentary Source Type: news
More News: Cancer & Oncology | Hematology | Immunotherapy | Melanoma | Neoadjuvant Therapy | Skin Cancer | Study | Surgery